Europe Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type, By End User, By Application, By Product Type, By Country and Growth Forecast, 2023

List of Tables

The Europe Rabies Vaccine Market would witness market growth of 4.1% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $101 Million by 2030. The UK market is exhibiting a CAGR of 3.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 4.9% during (2023 - 2030).

Professionals working in high-risk occupations, such as wildlife researchers, animal handlers, and veterinarians, may receive these vaccines to mitigate the risk of exposure during their work. This targeted vaccination strategy helps protect individuals regularly in close contact with animals, who may be more likely to encounter the rabies virus. These vaccines are crucial in emergency response situations, such as outbreaks or clusters of rabies cases.

Furthermore, dogs are the primary reservoirs and transmitters of the rabies virus to humans. Unvaccinated dogs carry a considerable risk of rabies transmission through bites in regions where the disease is endemic. The prevalence of dog bites, especially in areas with a high population of stray or unvaccinated dogs, underscores the urgent need for effective rabies vaccination programs.

Rabies is a zoonotic disease that threatens public health in France. The occurrence of rabies cases prompts public health authorities to implement preventive measures, including the vaccination of domestic animals and public awareness campaigns to reduce the risk of human exposure in France. Like many European countries, France has legal requirements for rabies vaccination of domestic animals, particularly dogs and cats. Veterinarians are pivotal in recommending and administering these vaccines to domestic animals in France. The increased incidence of rabies cases may lead to heightened awareness among pet owners, who are more likely to follow veterinary recommendations for vaccination in France. Thus, all these factors will uplift the regional market's expansion in the coming years.

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Boehringer Ingelheim International GmbH
Cadila Pharmaceuticals Limited
Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
Elanco Animal Health, Inc.
Zoetis, Inc.
Merck & Co., Inc.
Novartis AG
Bharat Biotech Ltd.
Sanofi S.A.
Virbac

Europe Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

Post-exposure Prophylaxis
Pre-exposure prophylaxis

By End User

Hospitals
Veterinary Clinics
Others

By Application

Human
Animal

By Product Type

Chick Embryo Cells Rabies Vaccine
Human Diploid Cell Vaccine
Vero cell rabies vaccine
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Europe Rabies Vaccine Market, by Prophylaxis Type
- 1.4.2Europe Rabies Vaccine Market, by End User
- 1.4.3Europe Rabies Vaccine Market, by Application
- 1.4.4Europe Rabies Vaccine Market, by Product Type
- 1.4.5Europe Rabies Vaccine Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Europe Rabies Vaccine Market by Prophylaxis Type

4.1Europe Post-exposure Prophylaxis Market by Country
4.2Europe Pre-exposure prophylaxis Market by Country

Chapter 5.Europe Rabies Vaccine Market by End User

5.1Europe Hospitals Market by Country
5.2Europe Veterinary Clinics Market by Country
5.3Europe Others Market by Country

Chapter 6.Europe Rabies Vaccine Market by Application

6.1Europe Human Market by Country
6.2Europe Animal Market by Country

Chapter 7.Europe Rabies Vaccine Market by Product Type

7.1Europe Chick Embryo Cells Rabies Vaccine Market by Country
7.2Europe Human Diploid Cell Vaccine Market by Country
7.3Europe Vero Cell Rabies Vaccine Market by Country
7.4Europe Others Market by Country

Chapter 8.Europe Rabies Vaccine Market by Country

8.1Germany Rabies Vaccine Market
- 8.1.1Germany Rabies Vaccine Market by Prophylaxis Type
- 8.1.2Germany Rabies Vaccine Market by End User
- 8.1.3Germany Rabies Vaccine Market by Application
- 8.1.4Germany Rabies Vaccine Market by Product Type
8.2UK Rabies Vaccine Market
- 8.2.1UK Rabies Vaccine Market by Prophylaxis Type
- 8.2.2UK Rabies Vaccine Market by End User
- 8.2.3UK Rabies Vaccine Market by Application
- 8.2.4UK Rabies Vaccine Market by Product Type
8.3France Rabies Vaccine Market
- 8.3.1France Rabies Vaccine Market by Prophylaxis Type
- 8.3.2France Rabies Vaccine Market by End User
- 8.3.3France Rabies Vaccine Market by Application
- 8.3.4France Rabies Vaccine Market by Product Type
8.4Russia Rabies Vaccine Market
- 8.4.1Russia Rabies Vaccine Market by Prophylaxis Type
- 8.4.2Russia Rabies Vaccine Market by End User
- 8.4.3Russia Rabies Vaccine Market by Application
- 8.4.4Russia Rabies Vaccine Market by Product Type
8.5Spain Rabies Vaccine Market
- 8.5.1Spain Rabies Vaccine Market by Prophylaxis Type
- 8.5.2Spain Rabies Vaccine Market by End User
- 8.5.3Spain Rabies Vaccine Market by Application
- 8.5.4Spain Rabies Vaccine Market by Product Type
8.6Italy Rabies Vaccine Market
- 8.6.1Italy Rabies Vaccine Market by Prophylaxis Type
- 8.6.2Italy Rabies Vaccine Market by End User
- 8.6.3Italy Rabies Vaccine Market by Application
- 8.6.4Italy Rabies Vaccine Market by Product Type
8.7Rest of Europe Rabies Vaccine Market
- 8.7.1Rest of Europe Rabies Vaccine Market by Prophylaxis Type
- 8.7.2Rest of Europe Rabies Vaccine Market by End User
- 8.7.3Rest of Europe Rabies Vaccine Market by Application
- 8.7.4Rest of Europe Rabies Vaccine Market by Product Type

Chapter 9.Company Profiles

9.1Cadila Pharmaceuticals Limited
- 9.1.1Company Overview
- 9.1.2Recent strategies and developments:
  - 9.1.2.1Product Launches and Product Expansions:
9.2Bharat Biotech Ltd.
- 9.2.1Company Overview
9.3Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
- 9.3.1Company Overview
9.4Boehringer Ingelheim International GmbH
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional & Segmental Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
9.5Elanco Animal Health, Inc.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5SWOT Analysis
9.6Zoetis, Inc.
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
9.7Merck & Co., Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Segmental and Regional Analysis
- 9.7.4Research & Development Expenses
- 9.7.5SWOT Analysis
9.8Novartis AG
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Segmental and Regional Analysis
- 9.8.4Research & Development Expense
- 9.8.5SWOT Analysis
9.9Sanofi S.A.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental and Regional Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
9.10.Virbac
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4SWOT Analysis

LIST OF TABLES

TABLE 1Europe Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2Europe Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5Europe Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 6Europe Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 7Europe Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 8Europe Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 9Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 12Europe Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 13Europe Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14Europe Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 16Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 17Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19Europe Human Market by Country, 2019 - 2022, USD Million
TABLE 20Europe Human Market by Country, 2023 - 2030, USD Million
TABLE 21Europe Animal Market by Country, 2019 - 2022, USD Million
TABLE 22Europe Animal Market by Country, 2023 - 2030, USD Million
TABLE 23Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 26Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 27Europe Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 28Europe Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 29Europe Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 30Europe Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 31Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 32Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 33Europe Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 34Europe Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 35Germany Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36Germany Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37Germany Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38Germany Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39Germany Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 40Germany Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 41Germany Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 42Germany Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 43Germany Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 44Germany Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 45UK Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 46UK Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 47UK Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 48UK Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 49UK Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 50UK Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 51UK Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52UK Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53UK Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 54UK Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 55France Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 56France Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 57France Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 58France Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 59France Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 60France Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 61France Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 62France Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 63France Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 64France Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 65Russia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 66Russia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 67Russia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 68Russia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 69Russia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 70Russia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 71Russia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 72Russia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 73Russia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 74Russia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 75Spain Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 76Spain Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 77Spain Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 78Spain Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 79Spain Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 80Spain Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 81Spain Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 82Spain Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 83Spain Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 84Spain Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 85Italy Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 86Italy Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 87Italy Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 88Italy Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 89Italy Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 90Italy Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 91Italy Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 92Italy Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 93Italy Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 94Italy Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 95Rest of Europe Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 96Rest of Europe Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 97Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 98Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 99Rest of Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 100Rest of Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 101Rest of Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 102Rest of Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 103Rest of Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 104Rest of Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 105Key Information - Cadila Pharmaceuticals Limited
TABLE 106Key Information - Bharat Biotech Ltd.
TABLE 107Key Information - Serum Institute of India Pvt. Ltd.
TABLE 108Key Information - Boehringer Ingelheim International GmbH
TABLE 109Key information - Elanco Animal Health, Inc.
TABLE 110Key Information - Zoetis, Inc.
TABLE 111Key Information - Merck & Co., Inc.
TABLE 112Key Information - Novartis AG
TABLE 113Key Information - Sanofi S.A.
TABLE 114Key Information - Virbac

Europe Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type, By End User, By Application, By Product Type, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents